Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tofacitinib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tofacitinibmarket, defines the market attractiveness level of Tofacitinib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tofacitinib industry, describes the types of Tofacitinib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tofacitinib market and the development prospects and opportunities of Tofacitinib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tofacitinib market in Chapter 13.
By Player:
Hetero Healthcare Ltd
Beacon Pharmaceuticals
Delta Pharma Limited
Drug International Limited
Globe Pharmaceuticals
Pfizer
By Type:
5mg*60 Tablets
5mg*10 Tablets
10mg*10 Tablets
5mg*30 Tablets
5mg*14 Tablets
10mg*14 Tablets
By End-User:
Rheumatoid Arthritis
Ulcerative Colitis
Psoriasis
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tofacitinib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tofacitinib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tofacitinib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tofacitinib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tofacitinib Market Analysis and Outlook to 2022
-
7.1 Global Tofacitinib Consumption (2017-2022)
-
7.2 United States Tofacitinib Consumption (2017-2022)
-
7.3 Europe Tofacitinib Consumption (2017-2022)
-
7.4 China Tofacitinib Consumption (2017-2022)
-
7.5 Japan Tofacitinib Consumption (2017-2022)
-
7.6 India Tofacitinib Consumption (2017-2022)
-
7.7 South Korea Tofacitinib Consumption (2017-2022)
8 Region and Country-wise Tofacitinib Market Analysis and Outlook to 2028
-
8.1 Global Tofacitinib Consumption Forecast (2022-2028)
-
8.2 United States Tofacitinib Consumption Forecast (2022-2028)
-
8.3 Europe Tofacitinib Consumption Forecast (2022-2028)
-
8.4 China Tofacitinib Consumption Forecast (2022-2028)
-
8.5 Japan Tofacitinib Consumption Forecast (2022-2028)
-
8.6 India Tofacitinib Consumption Forecast (2022-2028)
-
8.7 South Korea Tofacitinib Consumption Forecast (2022-2028)
9 Global Tofacitinib Market Outlook by Types and Applications to 2022
-
9.1 Global Tofacitinib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 5mg*60 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 5mg*10 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 10mg*10 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 5mg*30 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.5 Global 5mg*14 Tablets Consumption and Growth Rate (2017-2022)
-
9.1.6 Global 10mg*14 Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Tofacitinib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Psoriasis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Tofacitinib Market Outlook by Types and Applications to 2028
-
10.1 Global Tofacitinib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 5mg*60 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 5mg*10 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 10mg*10 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 5mg*30 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global 5mg*14 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global 10mg*14 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tofacitinib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Tofacitinib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tofacitinib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tofacitinib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tofacitinib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tofacitinib Market Competitive Analysis
-
14.1 Hetero Healthcare Ltd
-
14.1.1 Hetero Healthcare Ltd Company Details
-
14.1.2 Hetero Healthcare Ltd Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hetero Healthcare Ltd Tofacitinib Product and Service
-
14.2 Beacon Pharmaceuticals
-
14.2.1 Beacon Pharmaceuticals Company Details
-
14.2.2 Beacon Pharmaceuticals Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Beacon Pharmaceuticals Tofacitinib Product and Service
-
14.3 Delta Pharma Limited
-
14.3.1 Delta Pharma Limited Company Details
-
14.3.2 Delta Pharma Limited Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Delta Pharma Limited Tofacitinib Product and Service
-
14.4 Drug International Limited
-
14.4.1 Drug International Limited Company Details
-
14.4.2 Drug International Limited Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Drug International Limited Tofacitinib Product and Service
-
14.5 Globe Pharmaceuticals
-
14.5.1 Globe Pharmaceuticals Company Details
-
14.5.2 Globe Pharmaceuticals Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Globe Pharmaceuticals Tofacitinib Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Tofacitinib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tofacitinib
-
Figure Tofacitinib Picture
-
Table Global Tofacitinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tofacitinib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tofacitinib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tofacitinib Consumption by Country (2017-2022)
-
Figure United States Tofacitinib Consumption and Growth Rate (2017-2022)
-
Table Europe Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure China Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure Japan Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure India Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tofacitinib Consumption and Growth Rate (2017-2022)
-
Figure Global Tofacitinib Consumption Forecast by Country (2022-2028)
-
Figure United States Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tofacitinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5mg*60 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 5mg*10 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 10mg*10 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 5mg*30 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 5mg*14 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 10mg*14 Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Psoriasis Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 5mg*60 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5mg*10 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10mg*10 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5mg*30 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5mg*14 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 10mg*14 Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Psoriasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tofacitinib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tofacitinib Export by Region (Top 5 Countries) (2017-2028)
-
Table Hetero Healthcare Ltd (Foundation Year, Company Profile and etc.)
-
Table Hetero Healthcare Ltd Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hetero Healthcare Ltd Tofacitinib Product and Service
-
Table Beacon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Beacon Pharmaceuticals Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beacon Pharmaceuticals Tofacitinib Product and Service
-
Table Delta Pharma Limited (Foundation Year, Company Profile and etc.)
-
Table Delta Pharma Limited Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Delta Pharma Limited Tofacitinib Product and Service
-
Table Drug International Limited (Foundation Year, Company Profile and etc.)
-
Table Drug International Limited Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Drug International Limited Tofacitinib Product and Service
-
Table Globe Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Globe Pharmaceuticals Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Globe Pharmaceuticals Tofacitinib Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Tofacitinib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Tofacitinib Product and Service
-
